TRGT
Targacept Inc
Clinical-stage biopharmaceutical company developing neuronal nicotinic receptor (NNR) modulators to treat central nervous system diseases and disorders
CUSIP: 87611R306HealthcareUS1 holder
Recent Activity
2012Q1
1 sell
-6.00M shares
-6.00M shares
Loading more activity...